These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3433256)

  • 1. Inaccessibility to ligands of the amino-terminal region of plasma fibronectin.
    Homandberg GA
    Thromb Res; 1987 Nov; 48(3):321-7. PubMed ID: 3433256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two plasma fibronectin fragments with different gelatin-binding properties.
    Griffin CA; Calaycay J; Shively JE; Smith RL
    Thromb Res; 1986 Aug; 43(4):469-77. PubMed ID: 3532418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding site in human plasma fibronectin to HL-60 cells localizes in the C-terminal heparin-binding region independently of RGD and CS1.
    Fujita H; Mohri H; Kanamori H; Iwamatsu A; Okubo T
    Exp Cell Res; 1995 Apr; 217(2):484-9. PubMed ID: 7698249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of two binding domains for thrombospondin within fibronectin.
    Zafar RS; Zeng Z; Walz DA
    Arch Biochem Biophys; 1992 Sep; 297(2):271-6. PubMed ID: 1497347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin binds to amino-terminal fragments of plasma fibronectin.
    Homandberg GA; Kramer-Bjerke J
    Thromb Res; 1987 Nov; 48(3):329-35. PubMed ID: 3433257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fibronectin and its gelatin-binding domains with fluorescent-labeled chains of type I collagen.
    Ingham KC; Brew SA; Isaacs BS
    J Biol Chem; 1988 Apr; 263(10):4624-8. PubMed ID: 3127386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of secondary structure along the fibronectin molecule.
    Venyaminov SYu ; Metsis ML; Chernousov MA; Koteliansky VE
    Eur J Biochem; 1983 Oct; 135(3):485-9. PubMed ID: 6617646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alignment of biologically active domains in the fibronectin molecule.
    Ruoslahti E; Hayman EG; Engvall E; Cothran WC; Butler WT
    J Biol Chem; 1981 Jul; 256(14):7277-81. PubMed ID: 6788765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
    McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
    J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
    Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
    J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells.
    Dalton BA; McFarland CD; Underwood PA; Steele JG
    J Cell Sci; 1995 May; 108 ( Pt 5)():2083-92. PubMed ID: 7657726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the binding domains in the fragments cleaved by cathepsin G from human plasma fibronectin.
    Vartio T
    Eur J Biochem; 1982 Apr; 123(2):223-33. PubMed ID: 7075587
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment.
    Clark RA; Wikner NE; Doherty DE; Norris DA
    J Biol Chem; 1988 Aug; 263(24):12115-23. PubMed ID: 3403561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobic properties of porcine fibronectin and its functional domains.
    Hayashi-Nagai A; Kitagaki-Ogawa H; Matsumoto I; Hayashi M; Seno N
    J Biochem; 1991 Jan; 109(1):83-8. PubMed ID: 2016277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the NH2-terminal domain of fibronectin with heparin. Role of the omega-loops of the type I modules.
    Kishore R; Samuel M; Khan MY; Hand J; Frenz DA; Newman SA
    J Biol Chem; 1997 Jul; 272(27):17078-85. PubMed ID: 9202024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin.
    Radek JT; Jeong JM; Murthy SN; Ingham KC; Lorand L
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3152-6. PubMed ID: 8097314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NH2-terminal sequences of DNA-, heparin-, and gelatin-binding tryptic fragments from human plasma fibronectin.
    Pande H; Shively JE
    Arch Biochem Biophys; 1982 Jan; 213(1):258-65. PubMed ID: 7059179
    [No Abstract]   [Full Text] [Related]  

  • 19. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
    Zhu BC; Fisher SF; Pande H; Calaycay J; Shively JE; Laine RA
    J Biol Chem; 1984 Mar; 259(6):3962-70. PubMed ID: 6423638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible unfolding of the gelatin-binding domain of fibronectin: structural stability in relation to function.
    Isaacs BS; Brew SA; Ingham KC
    Biochemistry; 1989 Jan; 28(2):842-50. PubMed ID: 2713351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.